Qilian International Holding Group Limited
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian S… Read more
Qilian International Holding Group Limited (BGM) - Total Liabilities
Latest total liabilities as of March 2025: $23.90 Million USD
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has total liabilities worth $23.90 Million USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Qilian International Holding Group Limited - Total Liabilities Trend (2017–2024)
This chart illustrates how Qilian International Holding Group Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Qilian International Holding Group Limited Competitors by Total Liabilities
The table below lists competitors of Qilian International Holding Group Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PT Chemstar Indonesia Tbk
JK:CHEM
|
Indonesia | Rp69.69 Billion |
|
Pathfinder Ventures Inc
OTCQB:RVRVF
|
USA | $13.14 Million |
|
Botala Energy Ltd
AU:BTE
|
Australia | AU$2.87 Million |
|
Linkage Global Inc Ordinary Shares
NASDAQ:LGCB
|
USA | $33.96K |
|
GREENHY2 Ltd
AU:H2G
|
Australia | AU$1.25 Million |
|
Reward Minerals Ltd
AU:RWD
|
Australia | AU$7.59 Million |
|
Hensel Davest Indonesia Tbk PT
JK:HDIT
|
Indonesia | Rp61.95 Billion |
|
Treasure Global Inc.
NASDAQ:TGL
|
USA | $4.62 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Qilian International Holding Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qilian International Holding Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qilian International Holding Group Limited (2017–2024)
The table below shows the annual total liabilities of Qilian International Holding Group Limited from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | $8.91 Million | +29.01% |
| 2023-09-30 | $6.91 Million | -27.78% |
| 2022-09-30 | $9.56 Million | -48.82% |
| 2021-09-30 | $18.68 Million | -3.20% |
| 2020-09-30 | $19.30 Million | +52.82% |
| 2019-09-30 | $12.63 Million | -19.13% |
| 2018-09-30 | $15.62 Million | -20.82% |
| 2017-09-30 | $19.73 Million | -- |